SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US Listed > Biotechs > NanoViricides Inc. (NNVC)

In the next 5 years I'm expecting a

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
NotAsBigKahuna Member Profile
Member Level 
Followed By 250
Posts 19,290
Boards Moderated 3
Alias Born 10/03/04
160x600 placeholder
NanoViricides Files Quarterly Report for Period Ending 2017-03-31 "PR Newswire (US)" - 5/16/2017 7:50:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/15/2017 5:03:04 PM
NanoViricides CEO Dr. Seymour to Present an Update on the Company at The Planet Microcap Showcase - 2017 in Las Vegas; Compan... "PR Newswire (US)" - 4/26/2017 5:00:00 PM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 4/26/2017 6:02:18 AM
Securities Registration Statement (simplified Form) (s-3/a) "Edgar (US Regulatory)" - 4/18/2017 4:57:18 PM
Securities Registration Statement (simplified Form) (s-3) "Edgar (US Regulatory)" - 3/1/2017 6:10:07 AM
NanoViricides Files Quarterly Report for Period Ending 2016-12-31 "PR Newswire (US)" - 2/16/2017 7:00:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 2/14/2017 6:02:28 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/13/2017 5:33:10 PM
NanoViricides Reports the Company's Director Dr. Boniuk Converted Series B Debenture to Equity Effectively Raising $5M in New... "PR Newswire (US)" - 2/13/2017 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/3/2017 1:27:25 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/15/2016 4:54:24 PM
NanoViricides Publishes a Letter from the CEO to Shareholders on its Website "PR Newswire (US)" - 12/1/2016 7:00:00 AM
NanoViricides Files Quarterly Report for Period Ending 2016-09-30 "PR Newswire (US)" - 11/15/2016 7:00:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/14/2016 5:04:40 PM
NanoViricides President Dr. Diwan Gave Invited Talks on Regulatory Aspects of Nanomedicines "PR Newswire (US)" - 11/7/2016 7:00:00 AM
NanoViricides Signs Agreement with SUNY Upstate Medical Center for Testing of Its Drug Candidates for the Treatment of Shingl... "PR Newswire (US)" - 10/31/2016 7:00:00 AM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 10/28/2016 5:22:07 PM
NanoViricides Has Filed Annual Report, Says Company Has Sufficient Cash To Advance Into Clinical Trials "PR Newswire (US)" - 10/11/2016 7:00:00 AM
Annual Report (10-k) "Edgar (US Regulatory)" - 9/16/2016 4:53:47 PM
NanoViricides to Present at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City Today "PR Newswire (US)" - 9/13/2016 12:01:00 AM
NanoViricides Reports on Senator Murphy's Visit to the Company's Shelton Campus "PR Newswire (US)" - 8/25/2016 7:00:00 AM
NanoViricides Reports On Progress of Its Drug Candidates against Herpesviruses "PR Newswire (US)" - 6/20/2016 7:00:00 AM
NanoViricides to Present at the LDMicro Invitational Conference "PR Newswire (US)" - 6/9/2016 7:00:00 AM
NanoViricides to Present at the BIO2016 International Convention - on June 8, 2016, at 11a.m. Pacific Time "PR Newswire (US)" - 6/7/2016 7:00:00 AM
NotAsBigKahuna Member Level  Tuesday, 06/17/08 03:55:53 PM
Re: VERYLONGSTOPPEDDRINKINGTHEKOOLAID post# 13121
Post # of 132758 
In the next 5 years I'm expecting a 100 to 500 bagger fromn current prices. Simple matter of doing the math on approval and stockpiling of drugs for Influenza, HIV, EKC and HEP B and C.

Influenza = $3 billion
HIV = $3 billion
EKS = $3 bilion
HEP B & C = $3 billion

15% royalty for NNVC = $1.8 billion with a multiplier of 25 times earnings leaves a market cap of $45 billion or $300 a share. Now throw in one drug approval every 6 months and what do you get?


doc.feelgoode@yahoo.com

"It ain't what they call you, it's what you answer to." --WC Fields


SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist